Transient and constitutive MCF7 overexpression of Y537S or sorted by
relevance

Admin15.07.2021

Transient and constitutive MCF7 overexpression of Y537S or

7706
Admin05.09.2021

Transient and constitutive MCF7 overexpression of Y537S or

4606
Admin09.10.2021

(PDF) ERpS294 is a biomarker of ligand or mutational ERα

6205
Admin30.08.2021

Oncotarget | ERpS294 is a biomarker of ligand or

8704
Admin24.09.2021

Y537S ERa-and D538G ERa-containing tumors grow in the

Admin20.09.2021

(PDF) ERpS294 is a biomarker of ligand or mutational ERα

Admin24.09.2021

Genomic modelling of the ESR1 Y537S mutation for

Admin25.08.2021

(PDF) ERpS294 is a biomarker of ligand or mutational ERα

6504
Admin23.07.2021

Y537S ERa-and D538G ERa-containing tumors grow in the

6108
Admin13.07.2021

Metastasis and host animal survival after tail vein

6601
Admin09.08.2021

ZNF217 confers resistance to the pro-apoptotic signals of

7102
Admin02.09.2021

Global analysis of estrogen receptor beta binding to

6303
Admin21.08.2021

(a) Schematic representation of putative core HRE

6209
Admin24.08.2021

Emergence of Constitutively Active Estrogen Receptor-α

63010
Admin15.09.2021

Inducible expression of tyrosinase using the Tet-On

6906
Admin08.09.2021

ZNF217 confers resistance to the pro-apoptotic signals of

5300
Admin06.09.2021

Functional validation of novel ESR1 p.A569S mutation

1506
Admin18.08.2021

Telomerase reverse transcriptase inhibition stimulates

Admin30.07.2021

Induction of apoptosis in transient c-MET shRNA-knockdown

Admin12.09.2021

James M Way | Intarcia Therapeutics, Inc., CA

104
Admin13.09.2021

Smad7 Sensitizes Tumor Necrosis Factor-Induced Apoptosis

1905